Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 7 studies | 24% ± 7% | |
| classical monocyte | 7 studies | 22% ± 7% | |
| endothelial cell | 5 studies | 19% ± 2% | |
| retinal ganglion cell | 4 studies | 54% ± 27% | |
| monocyte | 3 studies | 22% ± 6% | |
| pancreatic A cell | 3 studies | 30% ± 10% | |
| conventional dendritic cell | 3 studies | 32% ± 8% | |
| neuron | 3 studies | 19% ± 2% | |
| myeloid cell | 3 studies | 26% ± 2% | |
| epithelial cell | 3 studies | 32% ± 0% | |
| GABAergic neuron | 3 studies | 25% ± 4% | |
| glutamatergic neuron | 3 studies | 38% ± 6% | |
| dendritic cell | 3 studies | 39% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 9897.95 | 1445 / 1445 | 100% | 57.03 | 183 / 183 |
| liver | 100% | 7072.79 | 226 / 226 | 100% | 84.94 | 406 / 406 |
| stomach | 100% | 7055.07 | 359 / 359 | 100% | 60.67 | 286 / 286 |
| lung | 100% | 8472.77 | 577 / 578 | 100% | 59.98 | 1155 / 1155 |
| intestine | 100% | 10056.38 | 966 / 966 | 100% | 52.27 | 526 / 527 |
| kidney | 100% | 8565.04 | 89 / 89 | 100% | 104.01 | 899 / 901 |
| breast | 100% | 5586.21 | 459 / 459 | 100% | 58.75 | 1113 / 1118 |
| prostate | 100% | 8571.20 | 244 / 245 | 100% | 66.45 | 501 / 502 |
| skin | 99% | 3728.77 | 1798 / 1809 | 100% | 108.19 | 472 / 472 |
| adrenal gland | 100% | 5922.38 | 258 / 258 | 99% | 73.25 | 227 / 230 |
| uterus | 100% | 7387.44 | 170 / 170 | 99% | 44.92 | 453 / 459 |
| bladder | 100% | 9162.90 | 21 / 21 | 99% | 46.80 | 497 / 504 |
| thymus | 100% | 5319.58 | 651 / 653 | 98% | 54.74 | 592 / 605 |
| brain | 97% | 5907.72 | 2567 / 2642 | 100% | 53.61 | 704 / 705 |
| pancreas | 96% | 3815.85 | 316 / 328 | 100% | 64.81 | 178 / 178 |
| ovary | 87% | 2658.48 | 157 / 180 | 96% | 30.02 | 414 / 430 |
| adipose | 100% | 6427.22 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 12692.57 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 154.17 | 80 / 80 |
| muscle | 100% | 20437.89 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 5793.79 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 38.85 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 14.74 | 1 / 1 |
| heart | 98% | 14423.48 | 842 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 90% | 27.06 | 26 / 29 |
| peripheral blood | 62% | 1602.82 | 572 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0042059 | Biological process | negative regulation of epidermal growth factor receptor signaling pathway |
| GO_0050860 | Biological process | negative regulation of T cell receptor signaling pathway |
| GO_0071364 | Biological process | cellular response to epidermal growth factor stimulus |
| GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
| GO_0050868 | Biological process | negative regulation of T cell activation |
| GO_0035335 | Biological process | peptidyl-tyrosine dephosphorylation |
| GO_0050922 | Biological process | negative regulation of chemotaxis |
| GO_0045931 | Biological process | positive regulation of mitotic cell cycle |
| GO_0046329 | Biological process | negative regulation of JNK cascade |
| GO_0016311 | Biological process | dephosphorylation |
| GO_0051893 | Biological process | regulation of focal adhesion assembly |
| GO_0043409 | Biological process | negative regulation of MAPK cascade |
| GO_0120183 | Biological process | positive regulation of focal adhesion disassembly |
| GO_0030336 | Biological process | negative regulation of cell migration |
| GO_1990264 | Biological process | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity |
| GO_0001772 | Cellular component | immunological synapse |
| GO_0005634 | Cellular component | nucleus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0017018 | Molecular function | myosin phosphatase activity |
| GO_0019901 | Molecular function | protein kinase binding |
| GO_0008138 | Molecular function | protein tyrosine/serine/threonine phosphatase activity |
| GO_0033549 | Molecular function | MAP kinase phosphatase activity |
| GO_1990782 | Molecular function | protein tyrosine kinase binding |
| GO_0016791 | Molecular function | phosphatase activity |
| GO_0008092 | Molecular function | cytoskeletal protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0030971 | Molecular function | receptor tyrosine kinase binding |
| GO_0004725 | Molecular function | protein tyrosine phosphatase activity |
| Gene name | DUSP3 |
| Protein name | Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR) Dual specificity phosphatase 3 protein-serine/threonine phosphatase (EC 3.1.3.16) Dual specificity protein phosphatase (EC 3.1.3.16) (EC 3.1.3.48) |
| Synonyms | VHR |
| Description | FUNCTION: Shows activity both for tyrosine-protein phosphate and serine-protein phosphate, but displays a strong preference toward phosphotyrosines. Specifically dephosphorylates and inactivates ERK1 and ERK2. . FUNCTION: Dual specificity phosphatase able to dephosphorylate phosphotyrosine, phosphoserine and phosphothreonine residues, with a preference for phosphotyrosine as a substrate. . FUNCTION: Dual specificity phosphatase able to dephosphorylate phosphotyrosine, phosphoserine and phosphothreonine residues, with a preference for phosphotyrosine as a substrate. . |
| Accessions | ENST00000590342.1 P51452 ENST00000226004.8 [P51452-1] ENST00000590935.1 ENST00000590753.1 K7ELG5 K7EPK5 K7ES89 B5BUI8 |